https://lcamarabic.org/amivantamab-plus-lazertinib-in-previously-untreated-egfr-mutated-advanced-nsclc/2025-06-16T13:05:52+03:00https://lcamarabic.org/osimertinib-with-or-without-chemotherapy-in-egfr-mutated-advanced-nsclc/2025-06-16T13:05:44+03:00https://lcamarabic.org/navigational-bronchoscopy-or-transthoracic-needle-biopsy-for-lung-nodules/2025-06-16T13:05:36+03:00https://lcamarabic.org/durvalumab-after-chemoradiotherapy-in-limited-stage-small-cell-lung-cancer/2025-06-16T13:05:26+03:00https://lcamarabic.org/news-title/2025-07-03T14:23:45+03:00https://lcamarabic.org/newsletter/2025-08-26T10:59:35+03:00https://lcamarabic.org/overall-survival-with-amivantamab-lazertinib-in-egfr-mutated-advanced-nsclc/2025-09-13T16:14:26+03:00